Literature DB >> 12373289

Protein expression of NF-kappaB in human colorectal adenocarcinoma.

Sofia Evertsson1, Xioa-Feng Sun.   

Abstract

NF-kappaB is a transcription factor believed to mediate a cellular survival response following the apoptotic stimulus TNF-alpha. To clarify the role of NF-kappaB in colorectal cancer, we investigated the relationship of NF-kappaB expression by immunohistochemistry with clinicopathological variables, and other factors including apoptotic index, bcl-2 expression, p53 and K-ras mutations in 138 colorectal adenocarcinomas. Eighty-seven (63%) tumours showed cytoplasmic and 51 (37%) nuclear NF-kappaB expression. Nuclear NF-kappaB was correlated with mucinous carcinomas (p=0.006) and was more apparent in the invasive margin of some tumours. A trend was seen between nuclear NF-kappaB expression and K-ras mutation (p=0.15). However, NF-kappaB was not correlated with gender, age, tumour location, Dukes' stage, survival, apoptotic index, bcl-2 expression and p53 mutations. Conclusively, NF-kappaB might be activated in more aggressive colorectal tumour cells, since both tumour cells in the invasive margin and the mucinous tumour cells could represent more aggressive tumour cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373289

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells.

Authors:  Sen Rong Yan; Robbie Randle Joseph; Kirill Rosen; Mauricio J Reginato; Amanda Jackson; Norman Allaire; Joan S Brugge; Christian Jobin; Andrew W Stadnyk
Journal:  Oncogene       Date:  2005-09-29       Impact factor: 9.867

2.  Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer.

Authors:  Anna Novell; Montserrat Martínez-Alonso; Moises Mira; Jordi Tarragona; Antonieta Salud; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2014-04-08       Impact factor: 4.064

3.  KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer.

Authors:  Gen Lin; Xiong-Wei Zheng; Chao Li; Qiang Chen; Yun-Bin Ye
Journal:  Dig Dis Sci       Date:  2012-04-24       Impact factor: 3.199

4.  Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy.

Authors:  Bert H O'Neil; William K Funkhouser; Benjamin F Calvo; Michael O Meyers; Hong Jin Kim; Richard M Goldberg; Stephen A Bernard; Laura Caskey; Allison M Deal; Fred Wright; Albert S Baldwin; Joel E Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-12       Impact factor: 7.038

5.  ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.

Authors:  Kensuke Kumamoto; Kaori Fujita; Reiko Kurotani; Motonobu Saito; Motoko Unoki; Nobutoshi Hagiwara; Hideaki Shiga; Elise D Bowman; Nozomu Yanaihara; Shu Okamura; Makoto Nagashima; Kotaro Miyamoto; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

6.  Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data.

Authors:  Rene Voboril; Jana Voborilova; Vlasta Rychterova; Tomas Jirasek; Josef Dvorak
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

7.  The prognostic factors and multiple biomarkers in young patients with colorectal cancer.

Authors:  Mo-Jin Wang; Jie Ping; Yuan Li; Gunnar Adell; Gunnar Arbman; Bjorn Nodin; Wen-Jian Meng; Hong Zhang; Yong-Yang Yu; Cun Wang; Lie Yang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

Review 8.  A Comprehensive View on the Quercetin Impact on Colorectal Cancer.

Authors:  Andreea-Adriana Neamtu; Teodor-Andrei Maghiar; Amina Alaya; Neli-Kinga Olah; Violeta Turcus; Diana Pelea; Bogdan Dan Totolici; Carmen Neamtu; Adrian Marius Maghiar; Endre Mathe
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.